Today, 2K announced King of Kings Edition, Attitude Era Edition, and Monday Night War Edition of WWE® 2K26, the newest ...

Former Michigan football coach Sherrone Moore has pleaded no contest to two misdemeanors in a criminal case that arose ...

A convicted robber who has lived in the North Country and robbed a bank in Merrimack in 2013 faces another stint in prison ...

TOKYO, March 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions ...

COLLEFERRO, IT / ACCESS Newswire / March 6, 2026 / Defense Systems and Solutions (DSS), a joint venture between Yulista ...

Eight years after the EC (European Commission) issued its "yellow card" warning over Illegal, Unreported and Unregulated (IUU ...

Two past critics of the Select Board were elected to join it Tuesday during Town Meeting, signaling a shift in local ...

Wendy's reports that limited-time offers at restaurants, fueled by FOMO and nostalgia, drive consumer cravings and boost ...

Phase 1 clinical trial of SL-325 ongoing, with data expected in the second quarter of 2026 –Phase 2 clinical trial of SL-325 in patients with Crohn’s disease expected to initiate ...

Abbie Greenleaf Library, built in 1912, is one of Franconia’s jewels in both its architecture and its content. It not only ...

Syntiant, a leading provider of full-stack, low-power embodied AI solutions from sensors to software, today announced it will have a ...

Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis.